Gefitinib Completed Phase 2 Trials for Adult Glioblastoma / Adult Giant Cell Glioblastoma / Adult Gliosarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00014170Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme